NCT01354418View on ClinicalTrials.gov

Bioequivalence of Single Dose Phenylephrine Extended Release Tablets and Phenylephrine HCl Immediate Release Tablets Dosed Every Four Hours (P08340)(COMPLETED)

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

May 31, 2011

Primary Completion Date

June 30, 2011

Study Completion Date

July 31, 2011

Conditions
Nasal Congestion
Interventions
DRUG

Phenylephrine HCl Extended Release

One phenylephrine HCl 30 mg extended release tablet orally

DRUG

Phenylephrine HCl Immediate Release

One phenylephrine HCl 10 mg immediate release tablet every 4 hours for three doses

Sponsors

Lead Sponsor

Bayer
All Listed Sponsors
lead

Bayer

INDUSTRY

NCT01354418 - Bioequivalence of Single Dose Phenylephrine Extended Release Tablets and Phenylephrine HCl Immediate Release Tablets Dosed Every Four Hours (P08340)(COMPLETED) | Biotech Hunter | Biotech Hunter